Avitar, Inc. (OTCMKTS:AVTI) shares traded up 33.3% during mid-day trading on Tuesday . The company traded as high as $0.00 and last traded at $0.00, 28,930,431 shares changed hands during mid-day trading. An increase of 10,177% from the average session volume of 281,499 shares. The stock had previously closed at $0.00.
Avitar Company Profile (OTCMKTS:AVTI)
Avitar, Inc is a holding company which through its subsidiaries designs, develops, manufactures, and markets diagnostic test products and proprietary hydrophilic polyurethane foam disposables for medical, diagnostics, dental, and consumer applications in the United States. It offers ORALscreen 4 and ORALscreen DRUGOMETER, the oral fluid-based onsite assay systems, for detecting drugs of abuse, such as opiates, including heroin, morphine, codeine, and synthetic opiates comprising oxycocone-oxycontin, percoset, and hydrocodone-vicodin; cocaine such as crack; marijuana; and methamphetamines, including meth and ecstasy.
Featured Story: How Investors Can Profit from Options Trading
Receive News & Ratings for Avitar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avitar and related companies with MarketBeat.com's FREE daily email newsletter.